R. B. Nussenblatt, Thompson, D. J. S., Li, Z., Chan, C. Chao, Peterson, J. S., Robinson, R. R., Shames, R. S., Nagarajan, S., Tang, M. Tao, Mailman, M., Velez, G., Roy, C., Levy-Clarke, G. A., Suhler, E. B., Djalilian, A., Sen, H. Nida, Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Mellow, S., Sran, P., Waldmann, T. A., and Buggage, R. R.,
“Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.”,
J Autoimmun, vol. 21, no. 3, pp. 283-93, 2003.
]